Literature DB >> 9585937

Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man.

G Wahl1, P Enyong, A Ngosso, J M Schibel, R Moyou, H Tubbesing, D Ekale, A Renz.   

Abstract

In North Cameroon, the vector of Onchocerca volvulus (causative agent of human onchocerciasis) also transmits 2 filariae of animals: O. ochengi from cattle and O. ramachandrini from wart hogs. In order to assess the qualitative and quantitative roles of these 'animal filariae' in the epidemiology of O. volvulus, the transmission of the 3 parasites was measured in 2 villages and related to the endemicity of human onchocerciasis. In Galim, a cattle-farming Guinea savanna village where wild animals are rare, the overwhelming majority of all filarial infections found in the Simulium damnosum s.l. vectors throughout the year were O. ochengi (89%). The remaining infections were mainly O. volvulus (10.5%), and a few O. ramachandrini (0.5%). In Karna, a crop-farming Sudan savanna village where cattle are rare, but wild animals common, flies were also more frequently infected with animal filariae than with the human parasite. In the dry season, when nomadic cattle are present, 54% of all infections were O. ochengi, 36% O. volvulus and 10% O. ramachindrini. In the rainy season, when the cattle move away, flies were mainly infected with O. ramachandrini (52% of all infections) and secondly with O. volvulus (48%). In Karna, the relationship between the Annual Transmission Potential (ATP) of O. volvulus and its prevalence in the human population conformed to other onchocerciasis foci, in that a moderate ATP led to hyperendemic onchocerciasis. In Galim, however, a 7-fold higher O. volvulus-ATP (caused by a very high biting rate of the flies) contrasted with a strikingly low endemicity of onchocerciasis. Since, at the same time, in Galim the transmission of O. ochengi (measured on man) was very high (15,000 L3/fly collector/year), we hypothesize that the reduced endemicity of onchocerciasis in Galim is due to 'natural heterologous vaccination' by the large annual number of O. ochengi-L3, inoculated into man by anthropo-boophilic S. damnosum s.l. The importance of micro-epidemiology for the understanding of the interlinkage of human and animal onchocerciasis is discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9585937     DOI: 10.1017/s003118209700228x

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  16 in total

1.  In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.

Authors:  Virginia L Tchakouté; Simon P Graham; Siv Aina Jensen; Benjamin L Makepeace; Charles K Nfon; Leo M Njongmeta; Sara Lustigman; Peter A Enyong; Vincent N Tanya; Albert E Bianco; Alexander J Trees
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

2.  Individual exposure to Simulium bites and intensity of Onchocerca volvulus infection.

Authors:  C A Jacobi; P Enyong; A Renz
Journal:  Parasit Vectors       Date:  2010-06-18       Impact factor: 3.876

3.  Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.

Authors:  Saskia I Johanns; Richard G Gantin; Bawoubadi Wangala; Kossi Komlan; Wemboo A Halatoko; Meba Banla; Potchoziou Karabou; Adrian Jf Luty; Hartwig Schulz-Key; Carsten Köhler; Peter T Soboslay
Journal:  PLoS Negl Trop Dis       Date:  2022-05-03

4.  TpUB05, a Homologue of the Immunodominant Plasmodium falciparum Protein UB05, Is a Marker of Protective Immune Responses in Cattle Experimentally Vaccinated against East Coast Fever.

Authors:  Jerome Nyhalah Dinga; Mark Wamalwa; Dieudonné Lemuh Njimoh; Moses N Njahira; Appolinaire Djikeng; Rob Skilton; Vincent Pryde Kehdingha Titanji; Roger Pellé
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

5.  Extracellular Onchocerca-derived small RNAs in host nodules and blood.

Authors:  Juan F Quintana; Benjamin L Makepeace; Simon A Babayan; Alasdair Ivens; Kenneth M Pfarr; Mark Blaxter; Alexander Debrah; Samuel Wanji; Henrietta F Ngangyung; Germanus S Bah; Vincent N Tanya; David W Taylor; Achim Hoerauf; Amy H Buck
Journal:  Parasit Vectors       Date:  2015-01-27       Impact factor: 3.876

6.  Onchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex.

Authors:  Poppy H L Lamberton; Robert A Cheke; Martin Walker; Peter Winskill; J Lee Crainey; Daniel A Boakye; Mike Y Osei-Atweneboana; Iñaki Tirados; Michael D Wilson; Anthony Tetteh-Kumah; Sampson Otoo; Rory J Post; María-Gloria Basañez
Journal:  Parasit Vectors       Date:  2016-08-05       Impact factor: 3.876

7.  Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.

Authors:  Albert Eisenbarth; Mbunkah Daniel Achukwi; Alfons Renz
Journal:  PLoS Negl Trop Dis       Date:  2016-02-29

8.  Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.

Authors:  Benjamin L Makepeace; Siv Aina Jensen; Sandra J Laney; Charles K Nfon; Leo M Njongmeta; Vincent N Tanya; Steven A Williams; Albert E Bianco; Alexander J Trees
Journal:  PLoS Negl Trop Dis       Date:  2009-11-10

9.  High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey.

Authors:  Stephen Raimon; Alfred Dusabimana; Gasim Abd-Elfarag; Samuel Okaro; Jane Y Carter; Charles R Newton; Makoy Yibi Logora; Robert Colebunders
Journal:  Pathogens       Date:  2021-05-14

10.  Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa.

Authors:  Gerard JJM Borsboom; Boakye A Boatin; Nico JD Nagelkerke; Hyacinthe Agoua; Komlan LB Akpoboua; E William Soumbey Alley; Yeriba Bissan; Alfons Renz; Laurent Yameogo; Jan HF Remme; J Dik F Habbema
Journal:  Filaria J       Date:  2003-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.